This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Han Wha Pharma Co., Ltd., Yang Ji Chemical Co., Ltd.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3 
1 out of 4 Years Active: 2018
Title: Young Soo Jo: Innovator in Janus Kinase Inhibition
Introduction
Young Soo Jo is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds that serve as therapeutic agents.
Latest Patents
Young Soo Jo holds a patent for a compound titled "Substituted N-(pyrrolidine-3-yl)-7H-pyrrolo[2,3-D]pyrimidine-4-amine." This innovative compound functions as a Janus kinase (JAK) inhibitor, which has potential applications in treating various diseases. The patent highlights the unique structure of the compound and its efficacy in inhibiting JAK activity.
Career Highlights
Throughout his career, Young Soo Jo has worked with notable companies such as Yang Ji Chemical Co., Ltd. and Han Wha Pharma Co., Ltd. His experience in these organizations has allowed him to refine his skills in drug development and innovation.
Collaborations
Young Soo Jo has collaborated with several professionals in his field, including Jong Min Kim and Chie Yeon Chough. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Young Soo Jo is a distinguished inventor whose work in Janus kinase inhibition showcases his commitment to advancing medicinal chemistry. His innovative contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile